Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Integr Biol (Camb). 2013 Jan;5(1):10.1039/c2ib20109g. doi: 10.1039/c2ib20109g

Fig 2. Co-culture with microparticle-injected BMDCs produces CD8 and CD4 proliferation in vitro.

Fig 2

BMDCs were incubated with 3-fold dilutions of microparticles or OVA (highest dose: 1µg/mL) for 1 day. Cells were then incubated with OT-I (CD8) or OT-II (CD4) T cells for 3 days. 1µCi/well 3[H]-thymidine was added for the final 8 hours of culture. A) Graph of CPM vs dose (amount of OVA in microparticles). Data shown are mean+SD. Two-way ANOVA was ***p<0.001 for OT-I and OT-II. B) CPM graphs for microparticles at 1µg/mL OVA with two-way ANOVA Dunnett’s post-hoc test. Microparticles are compared to OVA. ***p<0.001.